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Summary. Aldose reductase was purified from testis of non- 
diabetic BB rats using DEAE cellulose, hydroxylapatite and 
sephadex G-100 column chromatography. The molecular 
weight of the isolated enzyme was found to be 36,500___ 1000. 
Antibody against the isolated enzyme was raised in rabbits. It 
was purified by affinity chromatography, characterised by 
double immunodiffusion and Western blot analysis and used 
to localize the enzyme in retina and in peripheral nerve of 
the BB rat. In the retina, aldose reductase immunoreactivity 
was seen in the ganglion cells, Mtiller cell processes, retinal 
pigment epithelium and in the pericytes and endothelial cells 
of retinal capillaries. In peripheral nerve, aldose reductase 
immunoreactivity was found in the paranodal cytoplasm of 
Schwann cells and in pericytes and endothelial cells of 
endoneurial capillaries. 
Key words: Aldose reductase, BB rat, immunocytochemistry, 
retina, peripheral nerve. 
Hyperglycaemia has been suggested as pivotal to the 
pathogenesis of chronic diabetic complications such as 
nephropathy, neuropathy and retinopathy. Glucose 
levels in these target tissues reflects that of extracellular 
fluids, since glucose entry is neither acutely regulated 
by insulin nor is it rate limiting for the metabolism of 
these tissues [1, 2]. Metabolic events related to abnor- 
mal glucose metabolism in these organs, such as non- 
enzymatic glycosylation of proteins [3] and increased 
polyol pathway activity [2], may therefore play impor- 
tant roles in the development of chronic complications. 
The first class of enzymes in the polyol pathway, 
termed aldose reductases, are NADPH-requiring alde- 
hyde reductases which convert glucose and other al- 
dosugars to carbohydrate derived polyols. The second 
enzyme, sorbitol dehydrogenese, is an NAD + requir- 
ing dehydrogenase, which converts polyols to their 
corresponding keto-sugars [1]. Increased polyol path- 
way activity, subsequent to hyperglycaemia, has been 
invoked as an important pathogenetic factor in the 
development of several diabetic complications [2]. The 
osmotic effect of accumulated polyol is probably an 
important factor in the formation of diabetic cataract 
[1, 4, 5], whereas an osmotic basis for tissue damage is 
less well established in other target tissues. A further 
and probably more important consequence of in- 
creased polyol pathway activity is tissue depletion of 
myo-inositol, since aldose reductase inhibitors corn- 
pletely prevent the decrease in tissue myo-inositol in 
diabetic kidney [6], peripheral nerve [7] and blood ves- 
sel [8]. Myo-inositol depletion results in secondary 
changes in phosphoinositide metabolism that in turn 
lead to alteration in a series of membrane-bound en- 
zymes including Na+-K+-ATPase [9]. 
In peripheral nerve the reduced Na+-K+-ATPase 
function is directly related to nerve conduction slowing 
that occurs in animal and human diabetes [10, 11] and 
to impaired protein synthesis in diabetic spinal gangli- 
on cells [12]. The polyol and myo-inositol related 
Na+-K+-ATPase defect is also implicated in the early 
structural changes in  rat peripheral nerve [11, 13]. A 
similar mechanism may be involved in the breakdown 
of the blood-retinal barrier in diabetes [14]. Hence, in 
peripheral nerve we can logically relate hyperglycae- 
mia through a cascade of events involving polyol path- 
way activity and Na+-K+-ATPase function to defects 
in tissue structure and function. 
Aldose reductase exhibits significant qualitative 
and quantitative variations among tissues and species, 
and its distribution remains controversial [15, 16]. 
Therefore, to examine further the correlations between 
structural events in specific cell components of diabet- 
ic target tissues and increased polyol pathway activity, 
immunohistochemical localization of aldose reductase 
was undertaken in the BB rat. It is assumed by infer- 
ence that cells that normally demonstrate aldose reduc- 
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tase immunoreactivity may be succeptible to the conse- 
quences of increased polyol pathway activity in diabe- 
tes. 
The spontaneously diabetic BB rat is an authentic 
animal model  of human Type 1 (insulin-dependent) 
diabetes mellitus. Several diabetic complications devel- 
op in this model [17-20], and it therefore lends itself as 
an excellent model system to test the pathogenetic role 
of the polyol pathway. Since aldose reductase appears 
to be species specific [21], the enzyme was isolated 
from BB rat testis and antibody was raised in rabbits. 
The antibody was used for light microscopic immuno- 
cytochemical localization of the enzyme in the retina 
and peripheral nerve of the BB rat. 
Materials and methods 
Enzyme purification. Aldose reductase was purified using a modifica- 
tion of the method described by Ludvigson and Sorenson [22]. All 
steps were carried out at 4 ~ in the presence of 5 mmol/1 mercapto- 
ethanol. Eighty grammes of fresh testis from non-diabetic BB rats 
(Courtesy Dr. A.A. Like, Department of Pathology, University of 
Massachusetts Medical School, Boston, Mass, USA) were homogen- 
ized with a Polytron homogenizer (Brinkmann Instruments, Rexdale, 
Ontario, Canada) in 5 retool/1 tris buffer, pH 7.4, in a weight to vol- 
ume ratio of 1 : 2. The homogenate was centrifuged at 45,000 g for 
30 rain and the superuatant was collected. Solid ammonium sulphate 
in the amount of 17.5 g/100 ml was slowly added to the superuatant 
under gentle strirring to produce a saturation of 30%. The solution 
was allowed to stand for 1 h and the precipitate was removed by 
centrifugation at 15,000 g for 30 min. Additional solid ammonium 
sulphate in the amount of 30 g/100 ml was added to the superuatant 
to yield a saturation of 75%. The solution was again allowed to stand 
for 1 h and pellets were collected following centrifugation at 15,000 g 
for 30 rain [221. They were dissolved in 40 ml of 5 retool/1 tris buffer, 
pH 7.4, containing 5 mmol/l  mercaptoethanol. This solution was 
dialysed against 4 changes of each 800 ml of the same buffer using 
Spectropore no.2 membrane (45 mm diameter, 12,000-14,000 mol. 
wt. cut off). 
The dialysate was applied to a gravity packed DEAE cellulose 
column (2.5 x30 cm) equilibrated with 5 mmol/1 buffer (pH 7.4). 
The column was washed with the same buffer and eluted with a lin- 
ear NaC1 gradient (5-250 mmol/1); 7.5 ml fractions were then col- 
lected. 
The pooled fractions containing aldose reductase activity were 
concentrated by pressure dialysis using an Amicon filter with a 
YM 10 membrane, 10,000 tool. wt. cut off (Arnicon Corp., Danvers, 
Mass. USA) and applied to a gravity packed hydroxylapatite column 
(1.5 x 30 cm) equilibrated with 5 retool/1 Na-K phosphate buffer 
(pH 6.8). The column was subsequently washed with the same buffer 
and eluted with a linear 5-400 mmol/1 Na-K phosphate buffer gra- 
dient; 7.5 ml fractions were again collected. 
The fractions containing aldose reductase activity were pooled, 
concentrated by pressure dialysis and applied to a Sephadex G-100 
column (2.5 cm x 100 cm) equilibrated with 5 mmol/1 tris phosphate 
buffer (pH 7.4); 10 ml fractions were then collected. The pooled 
fractions containing enzyme activity were rechromatographed on a 
Sephadex G-100 column. The purified enzyme was dialysed to re- 
move mercaptoethanol and stored frozen ( - 2 0  ~ in small aliquots. 
The aldose reductase peak from the 2nd Sephadex G-100 run was 
used for immunization of rabbits. Other fractions showing enzyme 
activity were pooled to be used as pre-absorption controls for future 
immunohistochemical studies. The molecular weight of the isolated 
enzyme was determined by comparing it with standard molecular 
weight protein markers on sodium dodecyl sulphate polyacrylamide 
gels (SDS-PAGE). 
Enzyme assay and units. Aldose reductase was assayed according to 
Gabbay and Kinoshita [23]. Enzyme activity was measured spectro- 
photometrically at 340 nm in glass cuvettes of 1 cm light path. Gly- 
ceraldehyde and glucoronate were routinely used as substrates. The 
final concentrations of the reagents in the assay were 1 mmol/1 gly- 
ceraldehyde or 10 mmol/1 glucoronate, 73 ~tmol/1 of NADPH, 
5 retool/1 of mercaptoethanol and 67 mmol/1 of Na-K phosphate 
buffer (pH 6.2). The substrates were omitted from the control cu- 
vettes. The reaction was started by adding substrate to the test cu- 
vette and was followed on a LKB Ultrospec 4050 spectrophotometer 
(LKB Biochrom Ltd. Cambridge, England) at 25 ~ Aldose reduc- 
tase activity was indicated by the loss of NADPH absorbancy at 
340 nm. 
One unit of enzyme activity was defined as the amount of en- 
zyme that caused oxidation of 1 Ixmol NADPH per min. The specific 
activity was defined as units per mg protein. Protein concentrations 
were measured according to Lowry et al. [24]. 
Antibody preparation and identification. Antibodies against isolated 
aldose reductase were raised according to the following procedure. 
One milligramme of isolated enzyme in Freund's complete adjuvant 
(1:1, vol:vol) was injected subcutaneously in New Zealand rabbits. 
This was followed by the injection of two doses of 0.5 mg of the 
same enzyme in Freund's complete adjuvant at 2-week intervals; af- 
ter 2 further weeks an intravenous booster of 0.5 mg of the enzyme 
was given. The rabbits were bled after one week following the intra- 
venous booster injection. Serum was separated and the antibody was 
purified by affinity chromatography using CNBr activated sepha- 
rose. Purified protein was conjugated with sepharose and antiserum 
was added. Following incubation the antibody was eluted with gly- 
dne-HC1, neutralised with tris buffer and dialysed against phosphate 
buffered saline (PBS). Non-immune serum collected prior to the pri- 
mary immunisation was used as control serum for immunohisto- 
chemical studies. The antiserum was subjected to double immuno- 
diffusion on Ouchterlony plates against purified, semi-purified 
(hydroxylapatite peak), crude and heat inactivated (56 ~ for 15 rain) 
aldose reductase and also against the hexose dehydrogenase peak of 
the DEAE-cellulose elute. The specificity of the antibody was also 
judged by Western blot analysis on zeta-probe membrane against 
purified and crude enzyme. In vitro study for inhibition of enzyme 
activity was performed according to Gabbay and Cathcart [25]. Im- 
mune and non-immune serum absorbed with liver powder was used 
for this purpose. Ten gl of purified enzyme was incubated with in- 
creasing amounts of immune serum (10 ktl to 320 It) to a final vol- 
ume of 400 lxl. As control, non-immune serum was used. All samples 
contained 5 retool/1 of mercaptoethanol. The enzyme activity was 
assayed using glyceraldehyde as substrate after 20 rain of incubation 
at room temperature. 
Immunocytochemical procedure. Retina and sciatic nerves from 
5 non-diabetic BB rats were fixed overnight in Bouin's fixative and 
embedded in paraffin. Following deparaffinisation, the sections 
(15 from each tissue) were treated for 30 min with methanol contain- 
ing 0.05% H202 to block endogenous peroxidase activity, washed in 
PBS (5 minx  3) and incubated with normal serum for 2 h. Trypsin 
digested preparations of the retina were prepared as previously de- 
scribed in detail [18] and were incubated with 0.1% trypsin inhibitor 
solution for 30 min and then processed following the same method. 
The sections were washed with PBS and incubated with primary an- 
tibody for 24 h at 4 ~ Liver powder absorbed antiserum in the dilu- 
tion of  I : 500 was used, since this dilution was found to produce op- 
timum staining after trials with various dilutions ranging from 1 : 100 
to 1 : 2000. Liver powder absorbed non-immune serum was used as 
control. Following rinsing in PBS the sections were incubated with 
goat anti-rabbit IgG for 2 h at room temperature. The sections were 
then rinsed again in PBS and treated with rabbit peroxidase-antiper- 
oxidase (1 in "100) for 1 h at room temperature. The sections were 
again washed in PBS and incubated with freshly prepared 0.05% dl- 
aminobenzidine hydrochloride solution containing 0.01% H202 for 3 
to 8 rain, following which the sections were washed, dehydrated and 
mounted in Permount (Fisher Scientific Co., Fair Lawn, NJ, USA). 
Glyceraldehyde, sodium-D-glucoronate, and NADPH were ob- 
tained from Sigma Chemical Co., St. Louis, Mo, USA. Hydroxylapa- 
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Table 1. Results of the various purification steps of aldose reductase 
in the BB rat 
Specific Total Total Yield Purifi- 
activity protein activity (%) cation 
(unitsa/mg) (mg) (-fold) 
Crude 0.003 5950 17.85 100 1 
Sample for 0.006 2061 12.36 69.24 2 
DEAE 
cellulose 
Sample for 0.052 113 5.87 32.88 17.33 
H-apatite 
Sample for 0.062 77.58 4.80 26.89 20.66 
S-G100 
1st run 
Sample for 0.282 14.57 4.10 22.96 94 
S-G100 
2nd run 
Ar pool 0.283 10.27 2.90 16.24 94.33 
Ar peak 0.367 1.27 0.466 2.61 122.33 
One unit of enzyme activity was defined as the amount of enzyme 
that caused oxidation of  I lxmol NADPH per min. Ar: aldose reduc- 
tase 
tite and zeta-probe membrane were obtained from Bio-Rad Labora- 
tories, Richmond, Calif, USA. Sephadex G-100 and DEAE-cellulose 
and CNBr activated sepharose were obtained from Pharmacia Fine 
Chemicals, Uppsala, Sweden. 
Results 
Enzyme purification 
The purification procedure has been summarized in 
Table 1. Two enzyme activity peaks corresponding to 
two protein peaks were eluted from DEAE-cellulose 
column chromatography of ammonium sulphate pre- 
cipitated fractions of rat testis (Fig. 1). The first peak 
eluted in the column wash had a glyceraldehyde/glu- 
coronate reducing activity ratio of 1 : 4.2. The 2nd peak 
eluted after raising the NaC1 gradient had a glyceralde- 
hyde/glucoronate reducing activity ratio of 2.6:1. The 
first peak was identified as hexose dehydrogenase. The 
chromatography of the 2nd peak on hydroxylapatite 
column resulted in elution of two protein peaks, both 
appeared after raising the phosphate gradient. The en- 
zyme activity was only found in the first peak with a 
glyceraldehyde/glucoronate reducing activity ratio of 
3 : 1 (Fig. 2). 
Repeated gel filtration chromatography on Sepha- 
dex G-100 was performed with concentrated hydroxy- 
lapatite column eluted fractions containing aldose re- 
ductase activity for further purification of the enzyme. 
The second Sephadex G-100 run resulted in a sharp 
protein peak with high enzyme activity (Fig. 3). The 
fractions in this protein peak were separated and used 
for immunization. The whole procedure was repeated 
several times to yield the desired amount of purified 
enzyme. 
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Fig. 1. DEAE-cellulose column chromatography of dialysed ammo- 
nium sulphate precipitated fraction of  testis homogenate. - Protein 
profile as measured spectrophotometrically at 280 nm. 0-----0 En- 
zyme activity with glucoronate as substrate. A - - A  Enzyme activity 
with glyceraldehyde as substrate. O. D. = optical density 
~ 0.300 
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Fig.2. Hydroxylapatite column chromatography of the pooled 
DEAE-cellulose column eluted fractions containing aldose reductase 
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Fig.& Repeated Sephadex G-100 column chromatography of the 
pooled fractions containing aldose reductase activity from the 1st 
Sephadex G-100 column elute (see Figure 1 for legend) 
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Fig.4. SDS-PAGE electropho- 
resis from the aldose reductase 
peak of the repeated Sephadex 
G-100 column elute 
Fig. 5. Ouchterlony plate showing immunological identity of aldose 
reductase. Central well (Ab) - Antibody to aldose reductase. (1) Pu- 
rlried aldose reductase; (2) hydroxylapatite column eluted peak of 
aldose reductase; (3) crude extract from the testis of BB rat; (4) hex- 
ose dehydrogenase peak of DEAE-cellulose column elute 
The  iso la ted  e n z y m e  p e a k  was  sub jec ted  to SDS-  
P A G E  e lec t rophores i s  to de t e rmine  pur i ty  and  molec -  














Fig.6. a Westem blot analysis 
showing specificity of rabbit 
anti-rat aldose reductase anti- 
body. Antibody reacting with 
pure enzyme (left), and with 
crude enzyme (right). b Inhibi- 
tion of aldose reductase activity 
with increasing amount of im- 
mune serum (0----0). No inhi- 
bition of enzyme activity was 
noted when incubated with non- 
immune serum ( A - - A )  
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A N T I B O D Y  / E N Z Y M E  R A T I O  
weight  p ro te in  markers .  T h e  e n z y m e  s h o w e d  a single 
sha rp ly  de f ined  p ro te in  b a n d  with  a m o l e c u l a r  weight  
o f  36,500 + 1000 (Fig. 4). 
Identification and specificity of the antibody 
The  doub l e  i m m u n o d i f f u s i o n  test  on  O u c h t e r l o n y  
pla tes  wi th  an t i s e rum p r o d u c e d  a single b a n d  o f  preci-  
p i t a t ion  with  pur i f i ed  enzyme.  Single p rec ip i ta t ion  
b a n d s  were  also obse rved  w h e n  the  a n t i b o d y  was  al- 
l owed  to react  wi th  c rude  ext rac t  a n d  the  h y d r o x y l a p a -  
tite c o l u m n  e lu ted  e n z y m e  peak .  N o  prec ip i t a t ion  
b a n d  was  seen  be tween  the  a n t i b o d y  a n d  the  hexose  
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Fig.7 a-e. Photomicrographs of the retina from BB rat showing immunohistochemical stain- 
ing for aldose reductase, a Control. b Localization of aldose reductase in ganglion cell 
(arrowhead), Mi~ller cell processes (arrow) and in capillaries (hollow arrow), e Localization 
of aldose reductase in retinal pigment epithelium (arrow) and in choroidal blood vessel 
(arrowhead), SC = Sclera. d Tangential section through retinal vessels showing positive stain- 
ing. e Immunocytochemical staining of trypsin digested retinal preparation showing localisa- 
tion of aldose reductase in an endothelial cell (E), and in a pericyte (P) 
dehydrogenase peak of DEAE elute (Fig. 5). When the 
enzyme was heated to 56 ~ for 15 min there was no 
precipitation band formation. The specificity of the an- 
tibody was also confirmed by Western blot analysis, 
which showed a single band with both crude and puri- 
fied enzyme, and by the inhibition of enzyme activity 
when incubated with increasing amounts of immune 
serum but not with non-immune serum (Fig. 6 a, b). 
Immunocytochemical localization. In the retina aldose 
reductase immunoreactivity was found to be localized 
in Mtiller cell processes, ganglion cells, retinal pigment 
epithelium and in the walls of the blood vessels. Tryp- 
sin digested preparations of the retina showed immu- 
noreactive localization in both pericytes and endotheli- 
al cells (Fig.7a-e). In the sciatic nerve enzyme immu- 
noreactivity was seen in Schwann cells and was 
localized predominantly in the paranodal regions 
(Fig. 8 a, b). Endoneurial blood vessels demonstrated 
immunoreactivity in endothelial cells and pericytes 
(Fig. 8 c). No immunoreactivity was found in myelinat- 
ed axons. 
Discussion 
Aldose reductase is present in the Sertoli cells and in 
mature spermatids of the rat testis [22]. In this study we 
have demonstrated purification of this enzyme from 
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Fig.8 a-c. Photomicrographs from sciatic nerve of a BB rat showing immunohistochemical staining for aldose reductase, a Control b Local- 
ization of aldose reductase in the paranodal regions of the Schwan cells (arrow) (The preparation was counterstained with haematoxylin, evi- 
dent in Schwann cell nuclei) c Endoneurial capillary showing positive staining for aldose reductase in endothelial cells (arrows) and in a peri- 
cyte (hollow arrow) 
BB rat testis to a degree similar to that obtained by 
other investigators [22, 23]. Further purification was 
not undertaken because of possible loss of enzyme 
yield and stability [22]. The glyceraldehyde/glucoro- 
hate reducing ratio is a simple and useful criterion for 
the separation of aldose reductase from hexose dehy- 
drogenase in the DEAE-cellulose column elute [25]. 
Unlike Gabbay and Kinoshita [23], who found separa- 
tion of '  two isoenzymes on hydroxylapatite column 
chromatography of  bovine aldose reductase, no iso- 
enzymes were separated in this study. Our findings are 
therefore similar to the observations made by Ludvig- 
son and Sorenson on rat aldose reductase [22]. Sepha- 
dex G-100 column chromatography led to an increased 
purification yield with the removal of unwanted pro- 
tein. 
Since aldose reductase probably acts upon the 
aldehyde form of D-glucose in vivo, the discrepancy 
between in vivo activity of the enzyme and the low Km 
reported for D-glucose in purified enzyme prepara- 
tions [16, 26] raises the possibility of some alteration of 
the enzyme during purification. In the present study, 
however, a satisfactory purification was achieved as 
demonstrated by a single band on SDS-PAGE electro- 
phoresis as opposed to previous reports of triplet 
bands [22]. The estimated molecular weight of the en- 
zyme was 36,500 ___ 1000, which is similar to that previ- 
ously reported: 36,500 in rat seminal vesicle [22], 39,000 
in human placenta [27], 37,000 in bovine lens [28] and 
32,000 in bovine kidney [251. 
The formation of a single immunoprecipitation 
band after double immunodiffusion of  the antibody 
with purified, semi-purified and crude enzyme, and no 
immunoprecipitation band with hexose dehydroge- 
nase, demonstrate the specificity of the obtained anti- 
body. This is further supported by non-immunoreactiv- 
ity of heat inactivated enzyme, single bands on West- 
ern blot analysis with both crude and purified enzyme, 
and inhibition of enzyme activity by incubation with 
immune serum [25]. 
It is widely held that metabolic factors, such as ac- 
tivation of the polyol pathway conditioned by hyper- 
glycaemia, contribute to the characteristic structural al- 
terations in diabetic retinopathy and neuropathy [5, 7]. 
The finding of aldose reductase immunoreactivity 
in ganglion cells and in Mtiller cell processes of the re- 
tina is similar to the localization of this enzyme in the 
human retina [29]. In addition we have demonstrated 
immunoreactivity in the pigment epithelium and in en- 
dothelial cells and pericytes of retinal capillaries. Al- 
though there is no previous report on the localization 
of aldose reductase in retinal capillaries in paraffin 
embedded sections, enzyme immunoreactivity has 
been demonstrated in endothelial cells of rat aorta and 
muscular arteries [22] and in cultured bovine retinal 
and cerebral microvessels [30]. Isolated canine micro- 
vessels were also found to contain hexitol producing 
activity [31]. In the present study trypsin digested prep- 
arations showed positive immunoreactivity both in en- 
dothelial cells and in pericytes, whereas similar studies 
in humans showed localization of the enzyme in peri- 
cytes only [32]. Aldose reductase immunoreactivity in 
pigment epithelium of the BB rat may be relevant in 
explaining the pigment epitheliopathy in the diabetic 
BB rat retina [19]. The localization of the enzyme to 
retinal pericytes and endothelial cells in the BB rat 
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may explain previously described hydropic and de- 
generative changes of these cells, and may be a factor 
responsible for subsequent retinal thrombosis in this 
model [18]. 
An activated polyol pathway has been linked to the 
characteristic myo-inositol depletion and related 
Na+-K+-ATPase defect in diabetic peripheral nerve 
[10, 33]. These metabolic defects not only explain the 
rapidly reversible slowing of nerve conduction velocity 
in the acutely diabetic BB rat [11], but have also been 
invoked to explain paranodal swelling and subsequent 
axo-glial dysjunction. The latter is directly related to 
the less readily reversible nerve conduction defect in 
chronic diabetes [34]. These axonal swellings precede 
the loss of axo-glial dysjunctions in both the BB rat 
and man, and are ameloriated in the BB rat by the 
administration of an aldose reductase inhibitor and 
myo-inositol supplimentation, which prevent the 
Na+-K+-ATPase defect [13, 35]. Since aldose reduc- 
tase inhibitors but not myo-inositol supplimentation 
decrease nerve sorbitol levels, myo-inositol depletion 
and the associated Na+-K+-ATPase deficiency rather 
than sorbitol accumulation appears to underlie para- 
nodal axonal swelling. 
Aldose reductase immunoreactivity in endoneurial 
endothelium has not been previously demonstrated. 
This finding may be of importance in linking increased 
polyol pathway activity with endoneurial capillary clo- 
sure in diabetic peripheral nerve and in explaining a 
presumed ischemic pathogenetic influence on diabetic 
neuropathy [35-37]. 
Since naturally occuring proteins other than aldose 
reductase may share homologous sequences and there- 
fore may cross-react with antibodies raised against al- 
dose reductase, the possibility of false positive immu- 
nostaining exists and needs further clarification. On 
the other hand, failure of immunostaining of a particu- 
lar cell type such as the myelinated axon, however, 
does not exclude the possibility of an increased polyol 
pathway activity in such tissues in diabetes. However, 
findings that ligated diabetic sciatic nerve retains its 
ability to oxidize NADPH in the presence of glycer- 
aldehyde suggests that no significant amount of aldose 
reductase is present in or transported by the axon [38]. 
Ultrastructural immunocytochemical localization and 
quantification of aldose reductase in various cells of 
normal and diabetic rats is currently being performed 
in our laboratory. 
In summary, we have isolated and characterized a 
hexitol producing enzyme, aldose reductase, in the BB 
rat and demonstrated the immunoreactive distribution 
of the enzyme in the retina and peripheral nerve in this 
model. The present findings will serve as a basis for fu- 
ture studies in linking metabolic abnormalities with 
structural changes occurring in the target tissue of sec- 
ondary diabetic complications. 
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